GeNeuro SA
GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody, which has completed Phase IIb clinical tr…
Context Analysis
Competitors · Subsidiaries · Locations
The Contextualizer is eligible to "contextualize"
the market relationships of GeNeuro SA,
e.g. through tracking it's acquisitions, subsidiaries, offices,
fabrics and competitors around the globe.
Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.
U.S. · Business Intelligence
The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.
Worldwide · Business Intelligence
The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.
Worldwide · Competitors Table
Sourced from FMP or manual.
| Competitor | Private? | Source | Accuracy | Country | City |
|---|---|---|---|---|---|
| Transgene SA | FMP | High | France | Illkirch-Graffenstaden | |
| ABIVAX Société Anonyme | FMP | High | France | Paris | |
| GenSight Biologics S.A. | FMP | High | France | Paris | |
| Sensorion SA | FMP | High | France | Montpellier | |
| OSE Immunotherapeutics SA | FMP | High | France | Nantes |
Worldwide · Subsidiaries Table
Sourced from the SEC, through government awards and manual entries.
| Subsidiary | Private? | Country | City |
|---|---|---|---|
| - | - | - | - |